The utility of body FDG PET in staging primary central nervous system lymphoma.

@article{Mohile2008TheUO,
  title={The utility of body FDG PET in staging primary central nervous system lymphoma.},
  author={Nimish A. Mohile and Lisa M DeAngelis and Lauren Eileen Abrey},
  journal={Neuro-oncology},
  year={2008},
  volume={10 2},
  pages={223-8}
}
(18)F-Fluorodeoxyglucose (FDG) PET has become an important tool in the management of non-Hodgkin's lymphoma (NHL), but its role in the evaluation of primary CNS lymphoma (PCNSL) has not been established. We investigated the ability of body FDG PET to detect systemic disease in the staging and restaging of PCNSL. The records of 166 PCNSL patients seen at Memorial Sloan-Kettering Cancer Center were examined. Forty-nine patients who underwent body FDG PET for staging of PCNSL were identified… CONTINUE READING